New Delhi Tuberculosis Centre

What New Delhi Tuberculosis Centre does

New Delhi Tuberculosis Centre (NDTBC) is a Central Government-aided premier healthcare institution under the Ministry of Health & Family Welfare, Government of India, established in 1940 through a collaboration between the Tuberculosis Association of India and the Government of India. It provides comprehensive tuberculosis diagnosis, treatment, research, and training services free of cost under the National Tuberculosis Elimination Programme (NTEP), serving TB patients, drug-resistant TB cases, vulnerable populations, and healthcare professionals in Delhi NCR and northern India. The institution also acts as a referral centre for difficult cases from neighbouring states, receiving patients from Lok Nayak Hospital, GB Pant Hospital, and Guru Nanak Eye Centre. NDTBC supervises 25 chest clinics and 200 DOT centres across Delhi State and runs Active Case Finding campaigns targeting jail inmates, female sex workers, IV drug users, slum dwellers, and night shelter residents.

The centre operates six specialised sections — Administrative, Clinical, Epidemiology, Mycobacteriology, Public Health, and Training & Monitoring. Its diagnostic infrastructure spans sputum microscopy, CBNAAT, Line Probe Assay, MGIT 960 liquid culture with drug susceptibility testing (DST), Real-Time PCR, and Whole Genome Sequencing using Illumina MiSeq technology within a Biosafety Level III (BSL-3) laboratory. The laboratory is NABL ISO 15189:2022 accredited — the first government mycobacteriology laboratory in North India to achieve this — and is one of only five Whole Genome Sequencing facilities under NTEP. Clinical services include OPD consultations, DOTS treatment, specialty clinics for TB-Diabetes and TB-HIV co-infections, and a COAD Clinic for asthma and COPD. Educational offerings include modular training programmes for NTEP staff, a TB Health Visitor course accredited by the Central TB Division, and the Diagnostic Management Echo TB Clinic teleconsultation platform.

As a government entity, NDTBC operates without any commercial revenue model. All patient services are provided free of cost, funded through government grants-in-aid from the Tuberculosis Association of India and the Government of India, supplemented by Direct Benefit Transfers for nutrition support under the Nikshay Poshan Yojana. Its operating model is anchored in multi-stakeholder partnerships with the Central TB Division, ICMR, WHO, UNICEF, FIND, The Union, MRC London, and academic institutions including Maulana Azad Medical College, which together support research, training, and diagnostic kit validation. Over its 85+ year history, NDTBC has pioneered the 'Organised Home Treatment' concept later adopted as domiciliary treatment under the National TB Programme, conducted 8 longitudinal community-based prevalence surveys between 1962 and 1992, and produced an extensive publication record that has shaped national TB control policy.

Name

New Delhi Tuberculosis Centre

Legal name

New Delhi Tuberculosis Centre

Website

https://ndtbc.com

Company type

Private

Founded year

1940

Operating status

Operating

Headcount range

11–50 employees

Short description

NDTBC is a Central Government-aided premier institution under India's Ministry of Health & Family Welfare providing free tuberculosis diagnosis, treatment, research, and training under NTEP. It serves TB patients and drug-resistant cases across Delhi NCR and northern India through advanced molecular diagnostics, a BSL-3 reference laboratory, and outreach programmes.

Ownership category

akta.pro rank

Product category

Public Tuberculosis Healthcare Services

NAICS

Medical and Diagnostic Laboratories (62151), Outpatient Care Centers (6214), All Other Outpatient Care Centers (621498)

SIC

Services-Medical Laboratories (8071), Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Tuberculosis & Mycobacterial Diseases (HLAKAGAH)

akta.pro secondary industries

Local/County Public Health Laboratories (HLAJAIAC), Point-of-Care & Rapid Diagnostic Testing Centers (non-lab, non-imaging) (HLAFAKAO)

Keywords

• Tuberculosis diagnosis
• TB treatment services
• Public health laboratory
• TB reference laboratory
• TB training centre

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Others

Revenue model

1. Government Funded Public Healthcare Services: As a premier government institution under the Ministry of Health & Family Welfare, Government of India, the centre provides all diagnostic and treatment services free of cost under the National Tuberculosis Elimination Programme (NTEP). No commercial revenue model exists. Services are funded through government grants-in-aid from the Tuberculosis Association of India and Government of India.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

The New Delhi Tuberculosis Centre is a government-run healthcare institution that provides free tuberculosis diagnosis, treatment, and laboratory services to patients under India's National Tuberculosis Elimination Programme (NTEP). It also functions as a State TB Training and Demonstration Centre (STDC) and as an Intermediate Reference Laboratory (IRL), delivering training, quality assurance, and reference-level TB laboratory work alongside direct patient care.

Product overview

New Delhi Tuberculosis Centre (NDTBC) operates as a premier government healthcare institution providing integrated tuberculosis diagnosis, treatment, research, and training services. The centre offers a comprehensive portfolio of services including Outpatient Department consultations, Diagnostic Laboratory Services (sputum microscopy, CBNAAT/LPA, TB Culture, DST), Radiology Services (including digital X-ray), and DOTS treatment under NTEP. Specialized services include COAD Clinic for respiratory diseases, TB-Diabetes and TB-HIV co-management clinics, and teleconsultation through the Diagnostic Management Echo TB Clinic. The centre functions as an Intermediate Reference Laboratory (IRL) with NABL ISO 15189:2022 accreditation, offering advanced diagnostics including GeneXpert, Truenat, Line Probe Assay, MGIT 960 liquid culture, and Whole Genome Sequencing. Educational offerings include training programs for healthcare workers and a TB Health Visitor course. Research activities span operational studies, clinical trials, and diagnostic kit validation.

Differentiator

Problem solved

Functional benefit

Products and services

• TB Diagnosis Services Free tuberculosis diagnostic services for patients, provided on-site at the New Delhi facility under India's NTEP. These services are intended for individuals suspected of or being evaluated for TB disease and cover the standard sputum smear, culture, molecular, and other NTEP-approved diagnostic pathways available at the centre.
• TB Treatment Services Free anti-tuberculosis treatment and follow-up care provided to diagnosed TB patients under the NTEP, including drug dispensing, monitoring, and patient management for standard and drug-resistant TB. Treatment services are intended for individual patients registered at the centre and are delivered at no cost.
• NABL-Accredited TB Laboratory Services NABL ISO 15189:2022 accredited tuberculosis laboratory services, including culture, drug susceptibility testing, and molecular diagnostics, provided to support patient diagnosis, reference-level confirmation for other labs, and NTEP quality assurance activities.
• TB Training and Demonstration Programmes Training and demonstration programmes in tuberculosis prevention, diagnosis, treatment, and programme management, delivered under NDTBC's designation as a State TB Training and Demonstration Centre (STDC) since 2005. These programmes target medical officers, laboratory staff, and other NTEP personnel.
• Intermediate Reference Laboratory (IRL) Services Reference-level laboratory and quality assurance services delivered under NDTBC's designation as an Intermediate Reference Laboratory (IRL) since 2008, supporting other TB testing facilities with confirmatory and advanced diagnostic work.

Named customers6 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered minor and core.

• Medanta Medicity, GurugramminorOthers · 1 January 2024Supported active case finding among homeless pavement dwellers in Sangam Vihar and Chandini Chowk areas with mobile X-ray van.
• ICMR-TB Diagnostics Validation NetworkcoreStrategic or Co-development Partner · 1 January 2023IRL at NDTBC selected in 2024 as part of ICMR-TB Diagnostics Validation Network - exclusive network of limited laboratories for evaluation and validation of indigenously developed tuberculosis diagnostic kits.
• ICMR (Indian Council of Medical Research)coreStrategic or Co-development Partner · 1 January 2015Collaborative research partner for operational, clinical and laboratory research projects. ICMR supports National TB Prevalence Survey in India, multicentric clinical trials, and diagnostic kit validation studies. Centre has been associated with ICMR projects since 1955-57 for TB prevalence estimation.
• Central TB Division, Ministry of Health & Family WelfarecoreStrategic or Co-development Partner · 1 January 2015Primary government partner for implementing National Tuberculosis Elimination Programme (NTEP) activities. Certifies laboratory for LPA, culture, DST; provides programmatic guidance and funding for STDC activities; supports validation of new diagnostic modalities.
• FIND (Foundation for Innovative New Diagnostics)coreStrategic or Co-development Partner · 1 January 2015International partner supporting diagnostic kit validation studies and evaluation of novel TB technologies. Collaborates on multicentric studies and clinical trials for new diagnostic modalities.
• The Union (International Union Against Tuberculosis and Lung Disease)coreStrategic or Co-development Partner · 1 January 2015Collaborative partner for STREAM trial (evaluation of standard treatment regimen for MDR-TB patients), NATCON conferences, and programmatic evaluation. Contributed to baseline assessment of STDCs in India.
• MRC London (Medical Research Council)coreStrategic or Co-development Partner · 1 January 2015International research partner for multicentric clinical trials and operational research studies. Supported Short Course Chemotherapy trials during 1980s.
• Maulana Azad Medical College (MAMC)coreStrategic or Co-development Partner · 1 January 2015Academic partner providing faculty members as resource persons for training programmes. Undergraduate medical students, interns, and para-medical staff receive hands-on training in pulmonology and TB management. Faculty from MAMC contribute to training and evaluation activities.
• State TB Cell, DelhicoreStrategic or Co-development Partner · 1 January 2015State-level partner for coordination of training activities and NTEP implementation. Collaborates on capacity building programmes for medical and para-medical staff under NTEP.
• WHO and UNICEFcoreStrategic or Co-development Partner · 1 January 1951Initial supporters for establishment of first TB Demonstration cum Training Centre in 1951. WHO and UNICEF provided equipment for new sections (Epidemiology, BCG vaccination, Statistics) and laboratory and X-ray strengthening.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Others

• FIND (Foundation for Innovative New Diagnostics): International non-profit developing and validating new TB diagnostics. Functions as a partner/enabler rather than a competitor, collaborating with NDTBC on diagnostic kit validation and multicentric studies.
• Indian Council of Medical Research (ICMR): India's apex body for biomedical research and a long-standing research partner of NDTBC. Functions as a strategic enabler funding TB research, the TB Prevalence Survey, and the ICMR-TB Diagnostics Validation Network of which NDTBC is a member.

Direct peers

• Intermediate Reference Laboratories (IRL) network under NTEP: Network of state-level reference laboratories performing culture, DST, LPA, and molecular TB diagnostics under NTEP. NDTBC's IRL for Delhi is one node in this national network with identical scope, certifications, and programmatic reporting lines.
• National Institute for Research in Tuberculosis (NIRT), Chennai: ICMR-affiliated national TB research institute in Chennai conducting clinical, operational, and laboratory research on TB. Comparable to NDTBC on TB research output, ICMR collaborations, and diagnostic validation activities under NTEP.
• National Tuberculosis Institute (NTI), Bangalore: Government of India institute under the Directorate General of Health Services focused on TB training, demonstration, surveillance, and operational research. Highly comparable to NDTBC's STDC/IRL functions and its role in capacity building for state TB programmes.
• State TB Training and Demonstration Centre (STDCs), India (network): The network of 17 STDCs across India performs comparable functions to NDTBC's STDC mandate: training, monitoring, and IRL-level diagnostics for each state. NDTBC was adjudged the best-performing STDC in 2021, so peer STDCs are direct functional equivalents in other states.
• Vallabhbhai Patel Chest Institute (VPCI): University of Delhi-affiliated institute of chest diseases providing TB diagnosis, treatment, research, and post-graduate training. Highly comparable to NDTBC on patient services, diagnostics, and academic training in pulmonology and TB.
• National Institute of Tuberculosis and Respiratory Diseases (NITRD): Central government TB and respiratory diseases institute in Delhi under the Ministry of Health & Family Welfare. Operates as a tertiary care, training, and research institution on TB/respiratory medicine with comparable OPD, DOTS, BSL-3 lab, and DR-TB management services to NDTBC.

Broad incumbents

• World Health Organization (WHO) Global TB Programme: WHO sets global TB policy, norms, and standards that NTEP (and NDTBC) implement. WHO is a broader global incumbent in TB governance and a historical partner of NDTBC since 1951, providing strategic context rather than direct service competition.
• Stop TB Partnership: Global multi-stakeholder partnership hosted by UNOPS that coordinates TB elimination efforts worldwide. Functions as a broader incumbent in TB ecosystem policy, advocacy, and funding mobilisation that shapes NDTBC's operating environment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/new-delhi-tuberculosis-centre

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Delhi Tuberculosis Centre